22. January 2025 — Register here
From 12 January 2025 the EU HTA Regulation will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene therapies approved by the EMA. In just three years, by… read more
28. January 2025 to 28. November 2024 — Register here
Healthy populations are essential for Europe to achieve its vision of a secure, competitive, and prosperous continent. Yet, European health systems are navigating a perfect storm: ageing populations, rising chronic diseases, and a health workforce under strain. European societies are facing combined cost-of-living, geopolitical, and… read more
30. January 2025 — Register here
The TEHDAS2 stakeholder forum gathers experts, professionals and decision-makers in the health sector across Europe. The stakeholder forum showcases the first results of the TEHDAS2 project and advances the discussion on the development of the European Health Data Space (EHDS). The hybrid event takes place… read more
4. February 2025
This meeting is for EUCOPE Members only. For meeting details or the agenda, please contact Leander Vranken.
12. February 2025
This meeting is for EUCOPE Members only. For meeting details or the agenda, please contact Saskia Jansen.
13. February 2025 — Register here
Join EUCOPE and Sidley for the annual Life Sciences College (LSC), a day of in-depth discussions on cutting-edge trends with regulators from the European Commission (including overall pharmaceutical policy, DG COMP, and EHDS), reimbursement authorities (G-BA), investors, and industry leaders. LSC is an exclusive opportunity to engage… read more
25. February 2025 to 27. February 2025 — Register here
Bio-Neuroscience convenes innovators, CEOs and decision-makers in CNS neuroscience drug development from the leading biotech companies, investors and pharma companies in the sector. Investor and industry interest is booming, yet key challenges remain that can only be addressed by bringing together the leading translational research,… read more
5. March 2025 to 6. March 2025 — Register here
The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s. Join in Amsterdam for 2025! See here the agenda and speakers.
11. March 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Leander Vranken.
13. March 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Leander Vranken.
17. March 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens or Stefania Alessi.
25. March 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens.
1. April 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Leander Vranken.
19. June 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens.
24. June 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens or Stefania Alessi.
23. September 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens.
30. September 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens or Stefania Alessi.
4. December 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens.
11. December 2025 to 11. January 2025
This is for EUCOPE Members only. For meeting details or the agenda, please contact Victor Maertens or Stefania Alessi.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information